CD24 and breast carcinoma: We also compared the expression levels of miR-29a in 12 pairs of human breast cancer tissues and their corresponding distal non-cancerous tissues, and in a more aggressive breast cancer cell line, MDA-MB-231 cells, which contains high ratio of CD44+/CD24− cells (~80%).